Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
- Resource Type
- Source
- The Lancet Oncology. 24:483-495
- Subject
Oncology - Language
- ISSN
- 1470-2045